Brian Goff
CIK: 0001546216
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)DirectPerformance share units
39K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
39K shares- - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
Award(A)Direct9.2K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct6.6K shares at avg. $34.71$229K - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct25.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct12.5K shares at avg. $34.71$433K - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct13.5K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct18K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct8.3K shares at avg. $28.96$239K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct13K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct5.9K shares at avg. $28.96$171K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct8.5K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct3.9K shares at avg. $28.96$112K - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
48K shares- - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectStock options (right to buy)
174K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct12.8K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct25.5K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct12.5K shares at avg. $27.09$338K - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct6.2K shares at avg. $27.09$169K - Aug 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct22.7K shares- - Aug 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct11.1K shares at avg. $36.67$406K - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct25.5K shares- - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct12.5K shares at avg. $33.54$418K - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct12.8K shares- - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct6.2K shares at avg. $33.54$209K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) Performance share units | 39,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 39,000 | - | - | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award(A) | 9,200 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 6,596 | $34.71 | $228,947 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 25,528 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 12,472 | $34.71 | $432,903 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 13,500 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 18,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 8,267 | $28.96 | $239,412 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 13,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 5,918 | $28.96 | $171,385 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 8,500 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 3,870 | $28.96 | $112,075 | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 48,000 | - | - | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Stock options (right to buy) | 174,000 | - | - | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 12,750 | - | $0 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 25,528 | - | $0 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 12,473 | $27.09 | $337,894 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 6,230 | $27.09 | $168,771 | Direct |
| Aug 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 22,691 | - | - | Direct |
| Aug 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 11,085 | $36.67 | $406,487 | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 25,527 | - | - | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 12,471 | $33.54 | $418,277 | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 12,750 | - | - | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 6,229 | $33.54 | $208,921 | Direct |
1-25 of 32 transactions
About Goff Brian
Goff Brian (SEC CIK 0001546216) files insider reports with the SEC as Chief Executive Officer of AGIOS PHARMACEUTICALS, INC. (AGIO) and Director of Intellia Therapeutics, Inc. (NTLA).
Signal8 holds 9 ownership filings by Goff Brian, all Form 4s, filed between Mar 4, 2025 and Jun 23, 2026. Those filings report 32 transactions, from Mar 1, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goff Brian's filings is in CAMBRIDGE, MA.
Recent filings by Goff Brian
- Jun 18, 2026: Option exercise of AGIO derivative securities (Form 4, code M).
- Jun 18, 2026: Grant or award of AGIO derivative securities (Form 4, code A).
- Jun 9, 2026: Grant or award of NTLA shares (Form 4, code A).
- Apr 2, 2026: Open-market sale of AGIO shares (Form 4, code S).
- Apr 2, 2026: Option exercise of AGIO shares (Form 4, code M).
Other insiders filing for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Gheuens Sarah, Chief Medical Officer
- Backstrom Jay T., Director
- Ballal Rahul D., Director
- CAPELLO JEFFREY D, Director
- Foster-Cheek Kaye I, Director
- FOUSE JACQUALYN A, Director